September 19, 2013

San Francisco Business Times

Five Prime IPO carries on biotech boom

Five Prime Therapeutics Inc.'s $62 million stock debut Wednesday is getting good reviews on Wall Street so far, continuing the biotech industry's rise to investment favor.

Five Prime is the fourth Bay Area biotech initial public offering this year and is one of four nationally this week, including Fate Therapeutics Inc. of San Diego.

To reach the full article, visit:  http://www.bizjournals.com/sanfrancisco/blog/biotech/2013/09/ipo-five-prime-fprx-omed-ptla-kbio.html?page=all